https://mdtechcouncil.com/maryland-tech-council-announces-2024-icon-award-finalists/
SBIR grant from the NIAID (NIH) to investigate COVID-19-impacted type 2 diabetes
GlycoMantra has been awarded a two-year SBIR grant from the NIAID (NIH) to investigate COVID-19-impacted type 2 diabetes.